Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
LiveRamp
RAMP
$2.29B
| $5.16M | 0.01% |
293,645
-623,448
| -68% | -$11.2M |
|
1377
Tidewater
TDW
$4.59B
| $5.15M | 0.01% |
+7,026
| New | +$5.71M |
|
|
NETI
1378
DELISTED
Eneti Inc.
NETI
| $5.13M | 0.01% |
28,242
+20,157
| +249% | +$4.97M |
|
1379
TransDigm Group
TDG
$65.9B
| $5.13M | 0.01% |
22,832
-55,625
| -71% | -$12.5M |
|
1380
CALL
DuPont de Nemours
DD
$18.4B
| $5.12M | 0.01% |
+39,488
| New | +$5.12M |
|
1381
Itron
ITRI
$4.32B
| $5.11M | 0.01% |
148,389
-44,842
| -23% | -$1.63M |
|
1382
Liberty Media Series C
FWONK
$26.2B
| $5.1M | 0.01% |
200,807
+78,429
| +64% | +$2.11M |
|
1383
Nucor
NUE
$56.2B
| $5.1M | 0.01% |
115,700
+42,793
| +59% | +$2.05M |
|
|
SCS
1384
DELISTED
Steelcase
SCS
| $5.09M | 0.01% |
269,433
+256,635
| +2,005% | +$4.69M |
|
|
NS
1385
CALL
DELISTED
NuStar Energy L.P.
NS
| $5.08M | 0.01% |
85,600
+59,600
| +229% | +$3.77M |
|
|
TTOO
1386
DELISTED
T2 Biosystems, Inc
TTOO
| $5.08M | 0.01% |
63
+42
| +200% | +$3.64M |
|
|
GOLD
1387
DELISTED
Randgold Resources Ltd
GOLD
| $5.07M | 0.01% |
76,297
-137,826
| -64% | -$9.96M |
|
1388
Synaptics
SYNA
$3.71B
| $5.07M | 0.01% |
+58,402
| New | +$5.33M |
|
|
NPTN
1389
DELISTED
NEOPHOTONICS CORP
NPTN
| $5.05M | 0.01% |
553,638
+525,308
| +1,854% | +$3.98M |
|
1390
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.1B
| $5.05M | 0.01% |
106,131
+98,531
| +1,296% | +$4.81M |
|
1391
CALL
Celanese
CE
$4.89B
| $5.03M | 0.01% |
70,000
+40,000
| +133% | +$2.66M |
|
|
AERI
1392
DELISTED
Aerie Pharmaceuticals
AERI
| $5.02M | 0.01% |
284,251
-275,090
| -49% | -$5.04M |
|
1393
Euronet Worldwide
EEFT
$2.66B
| $5M | 0.01% |
81,102
-85,384
| -51% | -$5.08M |
|
|
INFI
1394
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $5M | 0.01% |
456,221
-435,001
| -49% | -$5.58M |
|
1395
Agree Realty
ADC
$9.24B
| $4.99M | 0.01% |
170,989
+23,374
| +16% | +$724K |
|
1396
Prudential
PUK
$35.3B
| $4.98M | 0.01% |
105,787
+61,639
| +140% | +$2.99M |
|
1397
Reinsurance Group of America
RGA
$16B
| $4.98M | 0.01% |
+52,485
| New | +$4.94M |
|
|
VXX
1398
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $4.98M | 0.01% |
+15,475
| New | +$5.04M |
|
|
AAN.A
1399
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $4.97M | 0.01% |
137,321
-143,533
| -51% | -$5.2M |
|
1400
TotalEnergies
TTE
$197B
| $4.97M | 0.01% |
+101,100
| New | +$5.23M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.